KCI

KCI believes all patients deserve the most advanced treatments available. KCI employees are focused on innovation and examining how to make science, and patient care, better for tomorrow. In over 20 countries around the world, KCI is improving patient outcomes, lowering costs and delivering the advanced treatments necessary to heal wounds and better the lives of patients. 

Their proprietary KCI negative pressure technologies have revolutionized the way in which caregivers treat a wide variety of wound types. The KCI Vacuum Assisted Closure®, or V.A.C.® Therapy System, has been clinically demonstrated to help promote wound healing. V.A.C.® Therapy has been used on more than 7 million wounds worldwide*. 

KCI are devoted to advancing the science of healing and positively impacting patient care by developing customer-driven innovation to meet the evolving needs of healthcare professionals. For over 35 years, KCI have led the way in the development of new technologies, medicines and therapies designed to make wound healing more manageable for caregivers and more comfortable for patients around the world. 

idsMED and KCI have been partnership for one year. With KCI, we commit to advancing healing technology that positively impacts the lives of patients, their families, caregivers and providers alike. The capabilities KCI has built in transforming wound care provide them with a road map to transform the practice of medicine in other areas and to continue successfully growing the company. 

Kinetic Concepts, Inc., (KCI) is a global corporation that produces medical technology related to wounds and wound healing. KCI produced the first product developed specifically for negative pressure wound therapy. KCI was founded in 1976 in San Antonio, Texas, by James R. Leininger, then an emergency room physician who wanted to help prevent the pulmonary complications associated with immobility. KCI has operations in Austria, Germany, the United Kingdom, Denmark, France, the Netherlands, Switzerland, Sweden, Italy, Canada, and Australia. Independent KCI equipment dealers penetrate 21 additional countries. Over time, the company developed or acquired a line of therapeutic specialty beds, introducing a specialty bed for acute care patients with pulmonary complications. Initially KCI’s product development focused on therapeutic beds and surfaces then expanded to introduce the first commercial negative pressure wound therapy products in the mid-1990s.